About
The videos provided in the Thrombosis Adviser channel are intended for viewers outside the USA and the UK.
Thrombosis Adviser is an online resource for physicians and patients about current and emerging therapies for thromboembolic disease including venous thrombosis (VTE), atrial fibrillation (AF), and acute coronary syndrome (ACS).
Imprint
Published by:
Bayer AG, Leverkusen, Germany
represented by the Management Board:
Werner Baumann, Chairman
Liam Condon, Hartmut Klusik, Kemal Malik,
Wolfgang Nickl, Stefan Oelrich, Heiko Schipper
Kaiser-Wilhelm-Allee 1
51373 Leverkusen, Germany
Tel.: +49 (0)214 30-1
E-mail: Inquiries can be sent to info@bayer.com or using our contact form.
Entry in the Commercial Register of the Cologne District Court
(Amtsgericht): HRB 48248
Turnover tax ID no.: DE 123659859
Edited by:
Bayer AG
Communications & Public Affairs
The videos provided in the Thrombosis Adviser channel are intended for viewers outside the USA and the UK.
Thrombosis Adviser is an online resource for physicians and patients about current and emerging therapies for thromboembolic disease including venous thrombosis (VTE), atrial fibrillation (AF), and acute coronary syndrome (ACS).
Imprint
Published by:
Bayer AG, Leverkusen, Germany
represented by the Management Board:
Werner Baumann, Chairman
Liam Condon, Hartmut Klusik, Kemal Malik,
Wolfgang Nickl, Stefan Oelrich, Heiko Schipper
Kaiser-Wilhelm-Allee 1
51373 Leverkusen, Germany
Tel.: +49 (0)214 30-1
E-mail: Inquiries can be sent to info@bayer.com or using our contact form.
Entry in the Commercial Register of the Cologne District Court
(Amtsgericht): HRB 48248
Turnover tax ID no.: DE 123659859
Edited by:
Bayer AG
Communications & Public Affairs